Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
L'intelligenza artificiale parla anche reatino. [...] dieci anni fa, in tempi ancora non sospetti c'era già chi, come Alessandro Acciai, aveva scelto di dedicare la propria vita allo studio delle architetture che emulano le reti neurali umane. [...] Trentasei anni e un curriculum che, dalla facoltà di Lettere e Filosofia di Roma Tre lo ha spinto verso la laurea magistrale in Scienze cognitive, fino alla Scuola internazionale superiore di studi avanzati di Trieste e alla Scuola di specializzazione del Cnr di Roma.
In edicola.
L'intelligenza artificiale parla anche reatino. [...] dieci anni fa, in tempi ancora non sospetti c'era già chi, come Alessandro Acciai, aveva scelto di dedicare la propria vita allo studio delle architetture che emulano le reti neurali umane. [...] Trentasei anni e un curriculum che, dalla facoltà di Lettere e Filosofia di Roma Tre lo ha spinto verso la laurea magistrale in Scienze cognitive, fino alla Scuola internazionale superiore di studi avanzati di Trieste e alla Scuola di specializzazione del Cnr di Roma.
Leggi l'articolo qui.
Facing an inhospitable environment with antisemitism and discrimination on campus, Harvard University academics have sought to engage in dialogue and discourse in Israel by joining a delegation of professors from six universities last Sunday. [...] Together they worked with Israel Destination to organize a delegation of 31 academics from Harvard, Stanford, Dartmouth, the Italian International School for Advanced Studies, and the University Kore of Enna.
Read the article here.
Facing an inhospitable environment with antisemitism and discrimination on campus, Harvard University academics have sought to engage in dialogue and discourse in Israel by joining a delegation of professors from six universities last Sunday. [...] Together they worked with Israel Destination to organize a delegation of 31 academics from Harvard, Stanford, Dartmouth, the Italian International School for Advanced Studies, and the University Kore of Enna.
Read the article here.
Si sono da poco conclusi tre workshop che hanno visto protagonisti gli allievi e le allieve di alcune classi dell'Isis Brignoli Einaudi Marconi di Staranzano e Gradisca, coadiuvati dai docenti, che hanno lavorato assieme a scienziati, videomaker, artisti, ricercatori e comunicatori scientifici, esplorando una zona affascinante e ancora poco conosciuta: il biotopo Schiavetti. [...] Curatore dei progetti Francesco Scarel, ricercatore, divulgatore e docente di comunicazione scientifica al Master della Sissa.
In edicola.
